Core Viewpoint - Hainan Puli Pharmaceutical Co., Ltd. announced that its stock and convertible bonds will be delisted, with the delisting period starting on April 28, 2025, and expected to last until May 21, 2025 [1][2][3] Group 1: Delisting Information - The convertible bonds will enter a delisting adjustment period for fifteen trading days, with the last trading date anticipated to be May 21, 2025 [1] - After the delisting, the company's stock and convertible bonds will be managed by the National Equities Exchange and Quotations (NEEQ) in a delisting board for transfer [3] - The Shenzhen Stock Exchange has decided to terminate the listing of the company's stock and convertible bonds as of April 18, 2025 [2] Group 2: Management and Compliance - The company is required to appoint a securities firm to provide services for the transfer of its stock and convertible bonds in the delisting board [3][4] - The company has signed an agreement with Guotai Junan Securities Co., Ltd. to act as the main underwriter for the transfer of its stock and convertible bonds [4] - The appointed underwriter will handle various administrative tasks, including registration and confirmation of shares and bonds in the delisting board [4][5]
普利退: 关于聘请主办券商的公告